Professional Summary
Professional Overview
Larry Rozsnyai is a seasoned intellectual property (IP) executive with over a decade of experience driving strategic IP management and commercialization initiatives in the life sciences industry. As the Vice President of Intellectual Property at Lycia Therapeutics, he is responsible for leading the company's IP portfolio development, licensing, and transactional activities to support its innovative drug discovery and development programs.
Experience Summary
Current Role
In his current role as the Vice President of Intellectual Property at Lycia Therapeutics, Larry is responsible for overseeing the company's global IP strategy and portfolio management. He works closely with the research and development teams to identify, protect, and leverage the company's IP assets to drive business growth and commercialization.
Under his leadership, Lycia has expanded its IP portfolio through the successful prosecution of several patents, securing key licensing agreements, and navigating complex IP-related transactions. Larry's strategic guidance has enabled the company to strengthen its competitive position and enhance its ability to attract investment and partnerships.
Career Progression
Prior to joining Lycia, Larry served as the Vice President of IP, Licensing, and Transactions at Olema Oncology, where he played a pivotal role in the company's IP and business development initiatives. Before that, he held the position of Vice President and Head of Intellectual Property at Myovant Sciences, where he was instrumental in building and managing the company's global IP portfolio to support its innovative pipeline of reproductive and women's health therapies.
Earlier in his career, Larry was Senior Counsel for Intellectual Property at Gilead Sciences and Senior Director of Intellectual Property and Legal Affairs at CymaBay Therapeutics (Metabolex). In these roles, he demonstrated his expertise in IP strategy, licensing, and transactions, contributing to the growth and success of these biotechnology companies.
Academic Background
Larry holds a Juris Doctor (J.D.) degree from the University of California, Berkeley, School of Law, where he specialized in intellectual property law. He also earned a Bachelor of Science (B.S.) degree in Biology from the University of California, Los Angeles, demonstrating his strong scientific foundation.
Areas of Expertise
- Intellectual property portfolio management and strategy
- Patent prosecution and portfolio optimization
- IP-related transactions, licensing, and deal negotiations
- Regulatory and compliance matters related to IP
- Cross-functional collaboration with R&D, business development, and legal teams
Professional Impact
Throughout his career, Larry has played a pivotal role in shaping the IP strategies and portfolios of several leading biotechnology companies. His contributions have been instrumental in securing valuable patents, negotiating strategic licensing agreements, and facilitating IP-driven transactions that have enabled his employers to strengthen their competitive positions and drive innovation in the life sciences industry.
Conclusion
With his extensive experience, deep technical knowledge, and strategic mindset, Larry Rozsnyai is a recognized IP leader in the life sciences sector. As the Vice President of Intellectual Property at Lycia Therapeutics, he is poised to continue driving the company's IP-focused initiatives and contributing to its long-term success.
